Results 31 to 40 of about 89,381 (309)

Dislocation of a cerebral protection device component during carotid stenting: A case report of favorable outcome from conservative management after failure of retrieval [PDF]

open access: yes, 2018
tINTRODUCTION: Cerebral-protection devices (CPDs) are a well-established system for reduction ofembolic risk in carotid artery angioplasty and stenting (CAS).
Avruscio, Giampiero   +3 more
core   +2 more sources

Atherosclerotic carotid plaque composition: a 3T and 7T MRI-histology correlation study [PDF]

open access: yes, 2016
Background and Purpose Carotid artery atherosclerotic plaque composition may influence plaque stability and risk of thromboembolic events, and non-invasive plaque imaging may therefore permit risk stratification for clinical management.
Condon, B.   +7 more
core   +1 more source

Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension

open access: yesEuropean Respiratory Review, 2017
Chronic thromboembolic pulmonary hypertension (CTEPH) is a type of pulmonary hypertension, resulting from fibrotic transformation of pulmonary artery clots causing chronic obstruction in macroscopic pulmonary arteries and associated vascular remodelling ...
D. Jenkins   +4 more
semanticscholar   +1 more source

Carotid artery stenting

open access: yesSwiss Medical Weekly, 2012
Atherosclerotic narrowing (stenosis) of the internal carotid artery accounts for about 10–15% of ischaemic strokes. Carotid endarterectomy (CEA) reduces the risk of stroke in patients with symptomatic stenosis and – to a lesser degree – with ...
Leo H. Bonati   +2 more
doaj   +1 more source

Coronary plaque burden predicts perioperative cardiovascular events after coronary endarterectomy

open access: yesFrontiers in Cardiovascular Medicine, 2023
Background and aimsThe risk factors of perioperative and long-term cardiovascular events in patients undergoing coronary artery bypass grafting (CABG) with adjunctive coronary endarterectomy (CE) are not well determined. This study evaluated the clinical
Mingxin Gao   +6 more
doaj   +1 more source

Peri-procedural brain lesions prevention in CAS (3PCAS). Randomized trial comparing CGuard™ stent vs. wallstent [PDF]

open access: yes, 2019
Background: Aim of this study was to evaluate peri-procedural incidence of new diffusion-weighted-magneticresonance- imaging (DWMRI) brain lesions in CAS patients treated by carotid mesh stent (CGuard™) or closed-cell stent (Wallstent™).
Capoccia, Laura   +7 more
core   +1 more source

Long-Term Results of Stenting versus Endarterectomy for Carotid-Artery Stenosis.

open access: yesNew England Journal of Medicine, 2016
BACKGROUND In the Carotid Revascularization Endarterectomy versus Stenting Trial, we found no significant difference between the stenting group and the endarterectomy group with respect to the primary composite end point of stroke, myocardial infarction,
T. Brott   +18 more
semanticscholar   +1 more source

ENDARTERECTOMY AND RECONSTRUCTION OF THE LEFT ANTERIOR DESCENDING ARTERY: IMMEDIATE AND LONG-TERM RESULTS

open access: yesВестник хирургии имени И.И. Грекова, 2018
An analysis of the results of treatment of 149 patients was made. The revasculization of the myocardium and the endarterectomy using the left anterior descending artery were carried out in these patients at the period from 2003 to 2010.
A. P. Bogdan   +2 more
doaj   +1 more source

Retinal Infarction: A Pilot Study on the Efficacy and Safety of Intravenous Thrombolysis and Underlying Aetiologies

open access: yesLife, 2022
Background: Treatment of non-arteritic central retinal artery occlusion is still inconsistent. Therefore, the current study aimed to evaluate the efficacy of intravenous thrombolysis (IVT) and describe the prevalence of co-occurring ischemic brain ...
Sonja Schönecker   +6 more
doaj   +1 more source

Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. [PDF]

open access: yes, 2013
BACKGROUND: Riociguat, a member of a new class of compounds (soluble guanylate cyclase stimulators), has been shown in previous clinical studies to be beneficial in the treatment of chronic thromboembolic pulmonary hypertension. METHODS: In this phase 3,
CHEST-1 Study Group,   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy